Megasoft to divest 36.5% in Swiss arm Extrovis AG for $15 mn
Megasoft Limited has decided to sell its entire 36.52 per cent holding in Extrovis AG, Switzerland, an associate company, for $15 million (about ₹128 crore). The company said the board has given its nod to the decision to sell the stake to Refex Life Sciences Private Limited.
The company said it will seek approval from its shareholders through a postal ballot in due course.
Published on July 1, 2025
Post Comment